Amgen
AMGN
NASDAQ
IPO1983
about AMGN
Amgen is a biotechnology company that develops innovative medicines to treat serious diseases, utilizing cutting-edge scientific research and technological advancements to improve patient outcomes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $340.36 | $340.88 | $328.63 | $183.17B | 2.90M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$5.98 | 19.38 | 18.69 | 26.43% | 33.65% | 2.89% |